Feasibility study to determine the external validity of the Diabetic Foot Screening Tool in detecting risk factors in the end stage renal disease population on haemodialysis therapy
MetadataShow full item record
Over the past three decades there has been a dramatic increase in the prevalence of End Stage Renal Disease (ESRD) which has heightened the global demand for renal replacement therapy. This is of particular importance because dialysis therapy is associated with high economic costs, a reduced quality of life and premature mortality relating from a wide range of metabolic complications.1One of the main challenges facing the Chronic Kidney Disease (CKD) population in Wales is that it currently has the highest incidence of haemodialysis therapy in the United Kingdom (UK). The impact of this is further compounded given that a high proportion of this population has diabetic nephropathy (28.2%) documented as their primary diagnosis.2 This may be attributed to the fact that social deprivation figures in Wales (48%) are substantially higher than in England (38%). It is estimated that people living in the most deprived areas in the UK are 2.5 times more likely to develop Type II diabetes as a consequence of poor nutritional choices and a sedentary lifestyle.
Diabetic Foot Journal;
Article accepted for publication in Diabetic Foot Journal
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))